Published in J Antimicrob Chemother on October 01, 1994
Susceptibility of Campylobacter fetus subsp. jejuni to twenty-nine antimicrobial agents. Antimicrob Agents Chemother (1978) 5.42
Bacteriostatic and bactericidal activities of 24 antimicrobial agents against Campylobacter fetus subsp. jejuni. Antimicrob Agents Chemother (1980) 2.71
Use of the polymerase chain reaction (PCR) for the detection of aacA genes encoding aminoglycoside-6'-N-acetyltransferases in reference strains and gram-negative clinical isolates from two Belgium hospitals. J Antimicrob Chemother (1993) 1.53
Susceptibility pattern of Campylobacter jejuni from human and animal origins to different antimicrobial agents. Antimicrob Agents Chemother (1982) 1.52
Characterization of the 6'-N-aminoglycoside acetyltransferase gene aac(6')-Im [corrected] associated with a sulI-type integron. Antimicrob Agents Chemother (1997) 1.51
Detection by polymerase chain reaction of genes encoding aminoglycoside-modifying enzymes in methicillin-resistant Staphylococcus aureus isolates of epidemic phage types. Belgian Study Group of Hospital Infections (GDEPIH/GOSPIZ). J Med Microbiol (1994) 1.34
In vitro antimicrobial sensitivity of Neisseria gonorrhoeae from Rwanda. Genitourin Med (1986) 1.29
In vitro activities of new antimicrobial agents against multiresistant Staphylococcus aureus isolated from septicemic patients during a Belgian national survey from 1983 to 1985. Antimicrob Agents Chemother (1990) 1.21
Macromolecular structure of lipopolysaccharides from gram-negative bacteria. Eur J Biochem (1973) 1.07
Disk sensitivity testing for Campylobacter jejuni. Eur J Clin Microbiol (1984) 1.06
Comparison of five different immunoassays for the detection of Borrelia burgdorferi IgM and IgG antibodies. Clin Microbiol Infect (2006) 1.03
Nomenclature of genes encoding aminoglycoside-modifying enzymes. Antimicrob Agents Chemother (1998) 1.02
In-vitro susceptibility of salmonellae to antimicrobial agents. J Antimicrob Chemother (1984) 0.92
Amoxicillin entry into human cerebrospinal fluid: comparison with ampicillin. Antimicrob Agents Chemother (1978) 0.91
Aminoglycoside resistance in Gram-negative blood isolates from various hospitals in Belgium and the Grand Duchy of Luxembourg. Aminoglycoside Resistance Study Group. J Antimicrob Chemother (1999) 0.91
Changes in major populations of methicillin-resistant Staphylococcus aureus in Belgium. J Hosp Infect (1996) 0.91
In-vitro activity of 21 antimicrobial agents against Neisseria gonorrhoeae in Brussels. Br J Vener Dis (1982) 0.90
Epidemic increase in Salmonella bloodstream infection in children, Bwamanda, the Democratic Republic of Congo. Eur J Clin Microbiol Infect Dis (2013) 0.89
Identification of the aadB gene coding for the aminoglycoside-2"-O-nucleotidyltransferase, ANT(2"), by means of the polymerase chain reaction. J Antimicrob Chemother (1992) 0.87
Rabies prophylaxis. Acta Clin Belg (1996) 0.85
The role of lipopolysaccharide anionic binding sites in aminoglycoside uptake in Stenotrophomonas (Xanthomonas) maltophilia. J Antimicrob Chemother (1995) 0.85
The comparative activity of pefloxacin, enoxacin, ciprofloxacin and 13 other antimicrobial agents against enteropathogenic microorganisms. Infection (1987) 0.85
Cefotaxime therapy of serious infections with multiresistant gram-negative bacilli. Scand J Infect Dis (1982) 0.84
The use of spa and phage typing for characterization of a MRSA population in a Belgian hospital: comparison between 2002 and 2007. Pathol Biol (Paris) (2009) 0.84
Ceftazidime activity on multiresistant salmonella. Lancet (1982) 0.83
Study of the structure of Shigella flexneri O antigen. I. Chemical degradation. Biochim Biophys Acta (1970) 0.83
Characterization of Staphylococcus aureus and Salmonella spp. strains isolated from bovine meat in Zaïre. Int J Food Microbiol (1991) 0.83
Three-year survey of amikacin use and aminoglycoside resistance in a general hospital in Belgium. Eur J Clin Microbiol Infect Dis (1988) 0.83
Study of the in vitro activity of amoxicillin/clavulanic acid and other beta-lactam antibiotics against Escherichia coli isolated from urine specimens. Acta Clin Belg (2001) 0.82
Ten years phage-typing of Belgian clinical methicillin-resistant Staphylococcus aureus isolates (1992-2001). J Hosp Infect (2004) 0.81
A 56-month prospective surveillance study on the epidemiology of aminoglycoside resistance in a Belgian general hospital. Scand J Infect Dis (1992) 0.80
In-vitro activity of antimicrobial agents against Neisseria gonorrhoeae in Brussels. Br J Vener Dis (1978) 0.79
Dual effects of pertussis toxin on in vitro invasive behavior of metastatic lymphoma variants. Clin Exp Metastasis (1989) 0.78
Comparative in vitro activity of cefepime and four extended-spectrum beta-lactams on 1,251 aminoglycoside-resistant gram-negative hospital strains. Chemotherapy (1992) 0.78
In vitro evaluation of the antibiotic susceptibility of Streptococcus pneumoniae: pneumococci relatively resistant to penicillin in Brussels. Acta Clin Belg (1980) 0.78
Moxalactam therapy of serious infections. Infection (1983) 0.78
Rapid purification of Bordetella pertussis toxin by alternating affinity and hydrophobic chromatography. Anal Biochem (1986) 0.78
[Chemotypes of "Shigella flexneri" R mutants and related phage receptors. II. -- Localization of phage receptors (author's transl)]. Ann Microbiol (Paris) (1976) 0.77
Specific non-immunoglobulin G antibodies and cell-mediated response to herpes simplex virus antigens in women with cervical carcinoma. Cancer Res (1977) 0.77
Favourable outcome in a patient bitten by a rabid bat infected with the European bat lyssavirus-1. Acta Clin Belg (2013) 0.76
[Septicaemia and spontaneous peritonitis in the cirrhotic (author's transl)]. Nouv Presse Med (1979) 0.76
Comparative in-vitro activities of amoxycillin and penicillin against Streptococcus pneumoniae isolates. J Antimicrob Chemother (1998) 0.75
In vitro study on the antimicrobial activity of various antibiotics against clinical isolates of Streptococcus pneumoniae from Belgium collected during winter 1998-1999. Acta Clin Belg (2001) 0.75
Activity of bicozamycin (CGP 3543/E) on different enteropathogenic micro-organisms: comparison with other antimicrobial agents. J Antimicrob Chemother (1982) 0.75
A change in Belgian epidemic methicillin-resistant Staphylococcus aureus phage types in 2000: phenotypic and genotypic characterization of isolates from a general hospital. J Hosp Infect (2005) 0.75
[Cefotaxime in the treatment of severe infections due to multiresistant Gram-negative bacilli (author's transl)]. Nouv Presse Med (1981) 0.75
Clinical and pharmacological evaluation of different preparations of oral erythromycin. Chemotherapy (1979) 0.75
Serotypes and extended spectrum beta-lactam resistance in aminoglycoside resistant Pseudomonas aeruginosa isolates from two Belgian general hospitals: a seven year study. J Hosp Infect (1993) 0.75
The "in vitro" susceptibility of urinary tract pathogens to mecillinam, compared with nine other antimicrobial agents. A multicenter study. Acta Urol Belg (1986) 0.75
Oral treatment of systemic Pseudomonas aeruginosa infection with enoxacin. Lancet (1984) 0.75
Evaluation of the in vitro activity of nifuroxazide on enteropathogenic microorganisms: determination of bacteriostatic and bactericidal concentrations and disk susceptibility. Acta Clin Belg (1981) 0.75
[Study of a "RFA" locus coding for cell wall lipopolysaccharide core biosynthesis in "Shigella flexneri" F6S (author's transl)]. Ann Microbiol (Paris) (1977) 0.75
Activity of cefotiam in combination with beta-lactam antibiotics on enterobacterial hospital strains. Pharm Weekbl Sci (1990) 0.75
In vitro susceptibilities of 176 clinical isolates of Streptococcus pneumoniae to 11 beta-lactams, erythromycin, and tetracycline. Acta Clin Belg (1996) 0.75
Cefotaxime and nephrotoxicity. Lancet (1979) 0.75
[Complementary study on the structure of a bacterial antigen]. Arch Int Physiol Biochim (1968) 0.75
[Hooping cough in adults, think about it!]. Rev Med Liege (2013) 0.75
[Antibacterial activity of carumonam and cefpirome on hospital strains resistant to gentamicin and cephalothin: comparison with other beta-lactam antibiotics, new fluoroquinolones, aminoglycosides and other antibiotics]. Pathol Biol (Paris) (1990) 0.75
Comparative in vitro activity of temocillin and other antimicrobial agents against Enterobacteriaceae isolated from patients admitted to five Belgian hospitals. Acta Clin Belg (2002) 0.75
[Receptor sites for phages specific for R mutants of Shigella flexneri]. Arch Int Physiol Biochim (1975) 0.75
Antimycobacterial activity of synthetic pamamycins. J Antimicrob Chemother (2004) 0.75
In vitro and in vivo activity of cefotaxime on gonococcal strains. J Antimicrob Chemother (1980) 0.75
[The structure of lipopolysaccharides from Gram-negative bacteria]. Arch Int Physiol Biochim (1973) 0.75
A one year survey on the epidemiology of aminoglycoside resistance in a general hospital: influence of amikacin. Acta Clin Belg (1986) 0.75
Study of the structure of Shigella flexneri O antigen. II. Physicochemical aspect. Biochim Biophys Acta (1970) 0.75
New phage type among methicillin-resistant Staphylococcus aureus associated with a local outbreak in Belgium during 2002. Clin Microbiol Infect (2006) 0.75
[Localization on the Shigella flexneri F6S chromosome of a rfa gene implicated in the biosynthesis of bacterial cell wall lipopolysaccharide]. Arch Int Physiol Biochim (1975) 0.75
Antibacterial activity of enoxacin: comparison with aminoglycosides, beta-lactams and other antimicrobial agents. J Antimicrob Chemother (1986) 0.75
[Chemotypes of "Shigella flexneri" R mutants and related phage receptors. I. -- Chemical study of the lipopolysaccharides (author's transl)]. Ann Microbiol (Paris) (1976) 0.75
Surveillance of pneumococcal resistance in Belgium during winter 1996-1997. Acta Clin Belg (1998) 0.75